Interestingly, Epac2A KOs exhibit early morphological (e.g., increased fat deposits) and biochemical (e.g., increased leptin and decreased adiponectin serum levels) signs of obesity, but these changes are connected with suppressed hypothalamic leptin signaling [51]. The gene discussed is LEP; the disease is obesity disorder.